Windtree Book Value Per Share from 2010 to 2025

WINT Stock

USD 1.66 0.04 2.35%

Windtree Therapeutics Book Value Per Share yearly trend continues to be comparatively stable with very little volatility. Book Value Per Share will likely drop to 16.84 in 2025. Book Value Per Share is the ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of Windtree Therapeutics according to its financial statements. View All Fundamentals

Book Value Per Share

First Reported

2010-12-31

Previous Quarter

17.73

Current Value

16.84

Quarterly Volatility

145 K

Credit Downgrade

Yuan Drop

Covid

Check Windtree Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Windtree Therapeutics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 89.6 K, Interest Expense of 54.6 K or Total Revenue of 0.0, as well as many indicators such as Price To Sales Ratio of 1.9 K, Dividend Yield of 0.0 or PTB Ratio of 2.67. Windtree financial statements analysis is a perfect complement when working with Windtree Therapeutics Valuation or Volatility modules.

Check out the analysis of Windtree Therapeutics Correlation against competitors.

For more information on how to buy Windtree Stock please use our How to Invest in Windtree Therapeutics guide.

Latest Windtree Therapeutics' Book Value Per Share Growth Pattern

Below is the plot of the Book Value Per Share of Windtree Therapeutics over the last few years. It is the ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of a company according to its financial statements. Windtree Therapeutics' Book Value Per Share historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Windtree Therapeutics' overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 5.90 X

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Book Value Per Share

Timeline

Windtree Book Value Per Share Regression Statistics

	Arithmetic Mean	41,317
	Geometric Mean	2,067
	Coefficient Of Variation	351.04
	Mean Deviation	68,148
	Median	2,274
	Standard Deviation	145,037
	Sample Variance	21B
	Range	593.7K
	R-Value	(0.45)
	Mean Square Error	17.9B
	R-Squared	0.20
	Significance	0.08
	Slope	(13,765)
	Total Sum of Squares	315.5B

Windtree Book Value Per Share History

	2025	16.84
	2024	17.73
	2023	15.41
	2022	250.3
	2021	1396.03
	2020	3477.6
	2019	7493.5

Other Fundumenentals of Windtree Therapeutics

Tangible Book Value Per Share

Windtree Therapeutics Book Value Per Share component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Total Liab	Total Current Assets	Short Term Debt	Common Stock	Current Deferred Revenue	Long Term Debt	Treasury Stock	Property Plant Equipment	Net Receivables	Net Tangible Assets	Long Term Debt Total	Capital Surpluse	Short Long Term Debt	Deferred Long Term Liab	Net Invested Capital	Net Working Capital	Good Will	Capital Stock	Intangible Assets
Total Assets		0.96	-0.46	-0.34	0.23	0.71	0.46	-0.25	-0.31	-0.16	0.02	-0.33	-0.1	0.29	0.34	0.19	0.46	-0.43	0.52	0.84	0.68	0.2	0.14	0.12
Total Stockholder Equity	0.96		-0.6	-0.13	0.09	0.5	0.51	-0.42	-0.14	-0.14	-0.13	-0.16	-0.09	0.07	0.42	0.05	0.29	-0.38	0.43	0.77	0.62	0.29	0.22	0.18
Net Debt	-0.46	-0.6		-0.26	0.04	-0.01	-0.91	0.45	0.09	-0.14	-0.15	0.14	0.08	0.14	-0.65	-0.18	0.29	-0.14	0.27	0.01	0.05	-0.48	-0.42	-0.36
Retained Earnings	-0.34	-0.13	-0.26		-0.11	-0.67	0.15	-0.11	0.77	-0.07	0.0	0.74	-0.55	-0.87	0.27	-0.03	-0.86	0.62	-0.72	-0.47	-0.61	0.52	0.55	0.62
Accounts Payable	0.23	0.09	0.04	-0.11		0.53	0.16	0.45	-0.32	0.22	0.6	-0.35	-0.58	0.26	0.18	0.61	0.0	0.44	-0.18	0.15	-0.13	0.41	0.46	0.48
Total Liab	0.71	0.5	-0.01	-0.67	0.53		0.2	0.3	-0.59	-0.11	0.44	-0.59	-0.08	0.63	0.02	0.54	0.68	-0.3	0.5	0.67	0.53	0.06	0.02	0.0
Total Current Assets	0.46	0.51	-0.91	0.15	0.16	0.2		-0.28	-0.2	0.05	0.48	-0.24	-0.19	0.03	0.73	0.47	-0.23	0.21	-0.32	-0.09	-0.18	0.41	0.41	0.37
Short Term Debt	-0.25	-0.42	0.45	-0.11	0.45	0.3	-0.28		-0.13	0.05	0.53	-0.15	-0.37	0.14	-0.34	0.47	-0.02	0.39	-0.23	-0.1	-0.21	0.23	0.23	0.25
Common Stock	-0.31	-0.14	0.09	0.77	-0.32	-0.59	-0.2	-0.13		-0.56	-0.24	0.99	-0.32	-0.94	0.0	-0.26	-0.43	0.24	-0.26	-0.2	-0.23	0.15	0.16	0.18
Current Deferred Revenue	-0.16	-0.14	-0.14	-0.07	0.22	-0.11	0.05	0.05	-0.56		-0.05	-0.58	0.09	0.36	0.04	-0.08	-0.28	0.31	-0.28	-0.22	-0.24	0.16	0.17	0.19
Long Term Debt	0.02	-0.13	-0.15	0.0	0.6	0.44	0.48	0.53	-0.24	-0.05		-0.28	-0.5	0.2	0.25	0.92	-0.16	0.47	-0.48	-0.27	-0.44	0.39	0.42	0.45
Treasury Stock	-0.33	-0.16	0.14	0.74	-0.35	-0.59	-0.24	-0.15	0.99	-0.58	-0.28		-0.28	-0.9	-0.02	-0.29	-0.38	0.2	-0.21	-0.21	-0.22	0.07	0.09	0.11
Property Plant Equipment	-0.1	-0.09	0.08	-0.55	-0.58	-0.08	-0.19	-0.37	-0.32	0.09	-0.5	-0.28		0.35	-0.14	-0.6	0.49	-0.55	0.55	0.03	0.37	-0.66	-0.74	-0.87
Net Receivables	0.29	0.07	0.14	-0.87	0.26	0.63	0.03	0.14	-0.94	0.36	0.2	-0.9	0.35		-0.12	0.22	0.6	-0.41	0.42	0.27	0.33	-0.36	-0.35	-0.34
Net Tangible Assets	0.34	0.42	-0.65	0.27	0.18	0.02	0.73	-0.34	0.0	0.04	0.25	-0.02	-0.14	-0.12		0.15	-0.27	0.17	-0.19	-0.07	-0.25	0.19	0.23	0.22
Long Term Debt Total	0.19	0.05	-0.18	-0.03	0.61	0.54	0.47	0.47	-0.26	-0.08	0.92	-0.29	-0.6	0.22	0.15		-0.08	0.36	-0.37	-0.07	-0.25	0.43	0.54	0.5
Capital Surpluse	0.46	0.29	0.29	-0.86	0.0	0.68	-0.23	-0.02	-0.43	-0.28	-0.16	-0.38	0.49	0.6	-0.27	-0.08		-0.73	0.91	0.65	0.77	-0.54	-0.57	-0.67
Short Long Term Debt	-0.43	-0.38	-0.14	0.62	0.44	-0.3	0.21	0.39	0.24	0.31	0.47	0.2	-0.55	-0.41	0.17	0.36	-0.73		-0.82	-0.6	-0.74	0.53	0.56	0.62
Deferred Long Term Liab	0.52	0.43	0.27	-0.72	-0.18	0.5	-0.32	-0.23	-0.26	-0.28	-0.48	-0.21	0.55	0.42	-0.19	-0.37	0.91	-0.82		0.78	0.88	-0.56	-0.6	-0.69
Net Invested Capital	0.84	0.77	0.01	-0.47	0.15	0.67	-0.09	-0.1	-0.2	-0.22	-0.27	-0.21	0.03	0.27	-0.07	-0.07	0.65	-0.6	0.78		0.89	0.02	-0.05	-0.1
Net Working Capital	0.68	0.62	0.05	-0.61	-0.13	0.53	-0.18	-0.21	-0.23	-0.24	-0.44	-0.22	0.37	0.33	-0.25	-0.25	0.77	-0.74	0.88	0.89		-0.19	-0.26	-0.44
Good Will	0.2	0.29	-0.48	0.52	0.41	0.06	0.41	0.23	0.15	0.16	0.39	0.07	-0.66	-0.36	0.19	0.43	-0.54	0.53	-0.56	0.02	-0.19		0.92	0.85
Capital Stock	0.14	0.22	-0.42	0.55	0.46	0.02	0.41	0.23	0.16	0.17	0.42	0.09	-0.74	-0.35	0.23	0.54	-0.57	0.56	-0.6	-0.05	-0.26	0.92		0.84
Intangible Assets	0.12	0.18	-0.36	0.62	0.48	0.0	0.37	0.25	0.18	0.19	0.45	0.11	-0.87	-0.34	0.22	0.5	-0.67	0.62	-0.69	-0.1	-0.44	0.85	0.84

Click cells to compare fundamentals

About Windtree Therapeutics Financial Statements

Windtree Therapeutics shareholders use historical fundamental indicators, such as Book Value Per Share, to determine how well the company is positioned to perform in the future. Although Windtree Therapeutics investors may analyze each financial statement separately, they are all interrelated. The changes in Windtree Therapeutics' assets and liabilities, for example, are also reflected in the revenues and expenses on on Windtree Therapeutics' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.

	Last Reported	Projected for Next Year
Book Value Per Share	17.73	16.84
Tangible Book Value Per Share	(114.26)	(108.55)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Windtree Stock Analysis

When running Windtree Therapeutics' price analysis, check to measure Windtree Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Windtree Therapeutics is operating at the current time. Most of Windtree Therapeutics' value examination focuses on studying past and present price action to predict the probability of Windtree Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Windtree Therapeutics' price. Additionally, you may evaluate how the addition of Windtree Therapeutics to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC